Comparison of Incidence and Severity of conjunctival hyperemia associated with use of topical Bimatoprost 0.01% and latanoprost 0.005% in Glaucoma or Ocular Hypertensive patients - ND

• Conditions: glaucoma or ocular hypertension; MedDRA version: 9.1Level: LLTClassification code 10018304; MedDRA version: 9.1Level: PTClassification code 10018304

• Registration Number: EUCTR2010-020213-82-IT
• Lead Sponsor: IRCCS- FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA-ONLUS

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-09-28
• Last Update Posted: 3 April 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

glaucoma and ocular hypertension
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

other major ocular diseases

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified